遺伝学：ヒトパンゲノムの概要参照配列が初めて発表される

First draft of a human pangenome

doi: 10.1038/s41586-023-05896-x

生物工学：遺伝子操作した細菌が、排ガスから工業化学物質を生産する

Biotechnology: Engineered bacteria produce industrial chemicals from waste gases

doi: 10.1038/s41587-021-01195-w

News In Brief

doi: 10.1038/nbt1104-1339

Illegal seeds overtake India',s cotton fields

doi: 10.1038/nbt1104-1333

Kenyan dispute illuminates bioprospecting difficulties

doi: 10.1038/nbt1104-1337

Industry wary of NIH consultancy moratorium

doi: 10.1038/nbt1104-1331

US NCI launches nanotechnology plan

doi: 10.1038/nbt1104-1335

バイオジェネリック薬に求められる類似性とは

p.1357

doi: 10.1038/nbt1104-1357

INVESTOR’S LAB

p.1363

doi: 10.1038/nbt1104-1363

バイオ製造業はパンク状態から好況期へ...バブルへ？

Biomanufacturing, from bust to boom...to bubble?

doi: 10.1038/nbt1104-1365

刊行と拒絶：特許法の下での拒絶事由

Publish and perish: what constitutes a bar under the patent laws

doi: 10.1038/nbt1104-1449

アブタマーを抗凝結薬に

Turning aptamers into anticoagulants

doi: 10.1038/nbt1104-1373

新たな光を浴びる蛍光タンパク質

Fluorescent proteins in a new light

doi: 10.1038/nbt1104-1374

DNAを鋳型として反応を発見する

DNA as a template for reaction discovery

doi: 10.1038/nbt1104-1378

アロステリックな相互作用の時間をみる

Finding time for allosteric interactions

doi: 10.1038/nbt1104-1376

RESEARCH HIGHLIGHTS

p.1381

doi: 10.1038/nbt1104-1381

抗凝血性アプタマーの解毒薬によるin vivo制御

Antidote-mediated control of an anticoagulant aptamer in vivo

doi: 10.1038/nbt1023

MHCペプチド複合体と強く結合する組換え型のT細胞受容体四量体

Engineered T-cell receptor tetramers bind MHC-peptide complexes with high affinity

doi: 10.1038/nbt1024

生物的相互作用クロマトグラフィーによるアロステリックな薬物－タンパク質結合の定量分析

Quantitative analysis of allosteric drug-protein binding by biointeraction chromatography

doi: 10.1038/nbt1022

哺乳動物細胞およびマウスでのガス誘導型導入遺伝子の発現

Gas-inducible transgene expression in mammalian cells and mice

doi: 10.1038/nbt1021

光切り換え型シアン蛍光タンパク質によるタンパク質の追跡

Photoswitchable cyan fluorescent protein for protein tracking

doi: 10.1038/nbt1025

How do RNA folding algorithms work?

doi: 10.1038/nbt1104-1457

A common open representation of mass spectrometry data and its application to proteomics research

doi: 10.1038/nbt1031

Promoter prediction analysis on the whole human genome

doi: 10.1038/nbt1032

Ask the experts: how to get hired

doi: 10.1038/nbt1104-1481

Reply to ',Monitoring horizontal gene transfer',

doi: 10.1038/nbt1104-1350

The Cartagena protocol and GMOs

doi: 10.1038/nbt1104-1347

Reply to ',Monitoring horizontal gene transfer',

doi: 10.1038/nbt1104-1349b

Monitoring horizontal gene transfer

doi: 10.1038/nbt1104-1349a

Changes in the business of culture

doi: 10.1038/nbt1104-1355

Glycoprotein sialylation in plants?

doi: 10.1038/nbt1104-1351

Quantum dots as photosensitizers?

doi: 10.1038/nbt1104-1360

Ethics, industry and ',animal farm',

doi: 10.1038/nbt1104-1348

Reply to ',Glycoprotein sialylation in plants?',

doi: 10.1038/nbt1104-1352

生物学的製品の製造工程変更に伴う特性確認および同等性評価

Characterizing biological products and assessing comparability following manufacturing changes

doi: 10.1038/nbt1030

酵母および糸状菌による医療用タンパク質生産の進歩

Advances in the production of human therapeutic proteins in yeasts and filamentous fungi

doi: 10.1038/nbt1028

大腸菌が折りたたむ組換えタンパク質の出来映え

Recombinant protein folding and misfolding in Escherichia coli

doi: 10.1038/nbt1029

哺乳動物培養細胞による組換えタンパク質製剤の生産

Production of recombinant protein therapeutics in cultivated mammalian cells

doi: 10.1038/nbt1026

組換えタンパク質生産のための植物培養細胞

Plant cell cultures for the production of recombinant proteins

doi: 10.1038/nbt1027

Patents

doi: 10.1038/nbt1104-1451

People

doi: 10.1038/nbt1104-1453

Thermocycling and High-throughput screening

doi: 10.1038/nbt1104-1455